• No results found

Accessible intelligence for decision makers

N/A
N/A
Protected

Academic year: 2021

Share "Accessible intelligence for decision makers"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

(1)

Accessible intelligence for decision makers

Pharmaceutical Market Europe

(2)

PME was relaunched in 2010 as a monthly print

title, after seven successful years as a quarterly

then bi-monthly publication. Written by experienced journalists and high-profi le pharma and healthcare experts, PME provides insights and offers solutions to the issues that keep industry leaders awake at night. From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector, PME’s got it covered.

Every month PME brings you:

• ‘Hot topics’ – Take a look behind the headlines and

examine the likely outcomes that could impact you and your day-to-day business planning

• Comment and analysis on the latest news – Gain

insights from top industry brains and academics

• Regulation in Europe and the US - Get a round-up

of major legislation across continents

• Innovation and pipelines – What is coming

through the ranks that could rival your brands?

• Business strategy section – Advice on the tools

needed to gain competitive advantage

• Market access – Theories and practicalities

behind one of the most important features on the industry landscape

• Industry leader interviews – What makes the

outstanding and emergent leaders in pharma and healthcare tick?

• Country Report – Explore the pharma and

healthcare sectors in Europe or beyond, in developed or developing markets [for more including partnership opportunities turn to page 6]

Also in every edition we bring you the latest

category developments in our Therapy Area Focus, along with careers advice and top industry moves across Europe.

PHarMaceuticaL MarKet eurOPe

Pharmaceutical Market Europe (PME) is a trusted source for decision makers and

infl uencers in the pharma and healthcare sectors who, through the practical and

accessible content, have the knowledge to tackle whatever comes their way

(3)

“PME allows me to remain informed on key industry news. It gives

me insights and valuable analysis on the whole pharma sector. The

digital version is user-friendly and an easy way to stay updated.”

Richard Bergstrom, Director-general,

European Federation of Pharmaceutical Industries and Associations

digital edition

You can also get each issue of PME

delivered straight to your inbox when

you register for digital editions.

http//:www.pmlive.com/register

PMe app

Join over 1,769 people who have downloaded the

free Pharmaceutical Market Europe (PME) app and

be among the fi rst to access the latest industry

news and analysis ‘on the move’, at a time to suit

you, via your iPad or iPhone.

Simply search for ‘PME’ in iTunes or the Apple App

Store to download the new app in time to read

these articles from the latest edition at http://

itunes.apple.com/us/app/id435487213?mt=8&ls=1

With the new app, not only can you read or

download the latest digital edition of PME, but you

can also access the PME archive. All the content

is fully searchable, with live weblinks, bringing a

wealth of additional content on a topic of interest

straight to you.

(4)

On average, PME reaches 16,054* highly

valuable decision makers and influencers in

the pharmaceutical and healthcare sectors

*combined print and digital circulation

Our audience

PME reaches the directors, senior executives and managers involved in strategic,

business and commercial decisions in pharma companies across Europe and also

the major companies servicing the sector

Service Sector

5189

Pharma Industry

10,865

France

1551

Germany

1407

Spain

966

Switzerland

1809

Italy

1202

5752

UK

Other

3367

“PME is an excellent source of important information on

developments in the European pharma market and I look

forward to reading the articles when the new issues arrive.”

Adam Barak, Head – International Pricing and Reimbursement,

United Biosource Corporation, London, UK

(5)

JOb TITLE bREAkDOWn

- PhARMA SECTOR

Total 10,827

Marketing

Managers

2192

Commercial

(includes Business Unit,

Business Development and

Commercial Directors)

1308

Procurement

362

Medical/

Clinical

1272

Other directors

(includes Digital,

Legal, Operations,

HR and Project

2248

Managing

Director

1664

619

Marketing

Director

General

Manager

305

CEO

422

Vice President

435

JOb TITLE bREAkDOWn

- SERvICE SECTOR

Total 5188

Marketing

530

Managing

Director

1125

888

CEO, VP, General

Manager, President

Consultant

89

Other directors (includes

Regulatory Affairs, Market

Research, Commercial,

Creative and Digital)

(6)

Globalisation and cultural mobility have narrowed the divide that once existed between nations not just

the developed and emerging markets, but between previously wealthy countries. Affordability and access to medicines dominate worldwide as once ‘affl uent’ nations face challenges of cost-containment and value.

What separates the different markets is the strategies they are developing to overcome these

hurdles. And while governments and the public in developed countries try their hand at being frugal, emerging markets are keen to learn from the mistakes made by the developed world.

In every issue of PME our Country Reports explore

this strategic and cultural diversity delving deep into the mechanics of national healthcare systems and the impact fi nancial constraints have on the pharma industry, access to medicines, and the appetite and ability to pay for innovation.

Through independent journalist-written editorial, we

will provide insights into some of the biggest questions industry has to answer. What can industry do to alleviate the economic burden? What role will collaborative working play in improving access to drugs?

ThE PACkAgE

The sponsorship package includes a company logo on every page of the report and a full-page ad facing the opening page of the report.

This is an exclusive offer; no other advertising will

appear within the report. Where appropriate we will attempt to ensure that we do not carry information in the editorial from rival organisations.

In addition, the report would be hosted on PMLiVE.com and therefore become the only reference work on that country until we tackle the region again. Its digital shelf life is extensive and the site receives over 60,000 page

impressions a month and has 14,000 registered users.

The cost for all of this is just £7500 for sponsorship of one Country Report.

COUnTRY REPORTS 2012

Australia India Brazil Italy China Mexico Denmark Russia France Spain Germany Turkey

cOuntrY rePOrt PartnersHiPs

eXPLOre

(7)

“PME is an excellent source of up to date and detailed information for all

those involved in the healthcare and biotech sectors. For EuropaBio, it is

also a key publication in terms of conveying the messages that matter to the

biotech industry today to many of our key stakeholders in the readership.”

Nathalie Moll, Secretary General, EuropaBio

The Thought Leader series in PME offers innovators and infl uencers the opportunity to discuss issues that are important to them, give them cause for

concern or are simply at the cutting-edge of healthcare. Each month the series explores a different topic of interest to decision makers in pharma.

This commercial opportunity offers thought leaders the perfect editorial platform from which to showcase their expertise, at a time when knowledge really is power. The cost for this is £3250 for which you get the piece in the magazine, a picture of the author and a PDF for your own use plus hosting in the digital magazine on PMLiVE.com – currently attracting 60,000 page impressions a month.

ThOUghT LEADER PIECES (ADvERTISIng)

PME 2012

Topics

Advertising

Business intelligence/market research CME Crisis management Digital Homecare Market access Medical education Nutraceuticals Pharmacy Reputation management Strategic Planning

tHOuGHt Leader OPPOrtunities

HaVe YOur saY

Why partner with us?

With a named, controlled circulation of 16,054 leading pharma and healthcare decision makers and infl uencers across Europe, PME should be a vital part in any media schedule.

(8)

Address: PMGroup

Mansard House, Church Road Little Bookham, Surrey, KT23 3JG Tel: +44 (0)1372 414200

Fax: +44 (0)1372 414201 Web: www.pmlive.com Editorial:

Linda Banks – [email protected]

Sales:

Chonell Roy – [email protected]

Paul Waddingham – [email protected] Gill Hollis – [email protected]

Production:

Samuel Hamilton – [email protected]

contact information

rates & data

(effective January 1, 2012)

DISPLAY RATES – FULL COLOUR

SIngLE InSERTIOn

Double-page spread (DPS) £5400/€6100 Full page £3250/€3675 Half page £2100/€2375 Third page £1750/€1980 Quarter page £1525/€1725

ThOUghT LEADERS

£3250/€3675

SPECIAL DISCOUnT FOR SERIES bOOkIngS

3 insertions 5% 6 insertions 10% 9 insertions 15% 12 insertions 20%

RECRUITMEnT RATES – FULL COLOUR

Full page £3450/€3900 Half page £2300/€2600 Quarter page £1550/€1750

JOb POSTIng On PMLIvE.COM

1 month from magazine ad FREE Early posting £50/€75 per job

Web only posting £500/€750 per job per 4 weeks Full terms and conditions available on request.

RATE CARD FOR PME SPECIALS

Inserts (up to 20gms, client supplied)

UK only Full Run

Loose in the bag £1750 £2500

In the magazine £2000 £2750

10 WAYS

Full run £7500 UK Only £5000

(+£500 for HTML version hosted on PMlive.com) The 10 Ways series offers you the opportunity to share your knowledge in a modular format with your peers and potential customers within the pharmacetuical industry. The four-page supplement is designed to educate those less familiar with a particular practice in 10 easy steps, thereby raising the credibility of the author as an expert in their chosen field.

PRICES AvAILAbLE On REqUEST:

Belly-band, Tabbed wrapper, Gatefold, Tip on

PME DIMEnSIOnS gUIDE

For technical specifications for display and recruitment advertisements, and information on inserts, please call Keith or Sam on +44 (0)1372 414200 or email [email protected].

References

Related documents

Explain using dunzo refer friend we spend my life time i offer every time saver for the referral program!. Active promotions found to dunzo app or shared network administrator to

We measure firm performance based on both financial and market indicators while capital structure is measures by leverage ratio of total debt to assets.. In addition

Thapisa notes that there is need to invest in LIS education that is more market driven, technopereneural in approach and competency based so that the graduates who are produced will

Comverse has combined its carrier-grade business support systems (BSS) and revenue management capabilities with a new set of Cloud-based enablement solutions to

In both data centers, all Cisco Nexus 7000 Series Switches are configured such that EIGRP process 100 is running on the interswitch link (Eth 2/9), interdata center link (Eth 1/2),

4 Under the New York State Constitution, cities outside of New York City are allowed to levy no more than 2% of the five-year average full valuation of taxable real

Central to the majority of these initiatives is a reassessment of the image that the city projects (Stevenson, 2003), which then becomes a key element in an

One important result of pre-planning content definition is that you can establish a continuity for the year. By that I mean continuity of appearance. For example a series of